guardian logo 2021

The world's first and only heart attack warning system

24/7 monitoring with real-time heart attack detection and patient alerts

The GUARDIAN is an implantable cardiac monitoring device which alerts the patient when a potential ACS event is detected, even in the absence of symptoms.

Programmed to match the individual patient, the GUARDIAN monitors the patient’s heart 24/7 and alerts the patient upon detection of signals related to acute coronary syndrome (ACS) events so the patient can seek medical care without delay.

real time heart attack alert
guardian patient

For patients who have had a prior cardiac event and are at high risk of a recurrent event

The GUARDIAN is indicated for use in patients who have had prior acute coronary syndrome (ACS) events and remain at high risk for recurrent ACS events.

The GUARDIAN device fills an unmet medical need by providing more effective diagnosis of a life-threatening condition when compared to patient symptoms alone

FDA Summary of Safety and Effectiveness Data (SSED) on file at Hydrix

The GUARDIAN is not available for supply in Australia and is currently not included on the Australian Register of Therapeutic Goods.